Sara Ek

Lund University is advertising tenure-track Assistant Professor positions in immunotherapy , immuno-oncology , and cancer immunotherapy within the Programme for Global Excellence in Lund, Sweden. The post spans several closely related research directions: Immuno-Oncology & Immune Cell Engineering (Faculty of Medicine), Immunotechnology – Cancer Immunotherapy (Faculty of Engineering), and Experimental Cancer Immunotherapy (Translational Cancer Research). The research themes include immune cell engineering, cancer immunology, translational cancer research, and experimental immuno-oncology approaches. Applicants are expected to hold a PhD and/or MD and to have a strong background in immuno-oncology, immunotherapy, or a related field. The post also emphasizes research excellence and independence . The announcement is aimed at outstanding researchers with interest in cancer immunotherapy. This is a full-time tenure-track academic appointment. The post mentions an attractive start-up package , but does not describe a scholarship, tuition waiver, or student stipend. Deadlines listed in the post are: 26 May 2026 for Immunotechnology, 10 June 2026 for Experimental Cancer Immunotherapy, and 30 June 2026 for Immuno-Oncology & Immune Cell Engineering. The latest deadline is used here for the overall post. Contacts named in the post include Sara Ek , Kristian Pietras , and Filipe Pereira . The application link provided in the post points to Lund University’s Varbi recruitment portal.

Lund University in Sweden is recruiting three tenure-track Assistant Professors as part of its Programme for Global Excellence to strengthen research in immunotherapy and immuno-oncology . The openings span three closely related areas: Immunotechnology with a focus on cancer immunotherapy , Immuno-Oncology and Immune Cell Engineering , and Experimental Cancer Immunotherapy . The posts are based at Lund University units including the Department of Immunotechnology, the Division of Immuno-Oncology, and the Division of Translational Cancer Research. These are tenure-track faculty positions with a clear path to promotion and an attractive start-up package. The post is aimed at outstanding researchers who can build an internationally competitive programme at the interface of immune engineering , mechanistic discovery , and clinical translation . Eligibility highlights vary slightly by position, but candidates are expected to hold a PhD ; one position accepts PhD and/or MD . A strong background in the relevant research area is required, especially in cancer immunotherapy, immuno-oncology, immunotechnology, or immune cell engineering. Deadlines shown in the post are 26 May 2026 for Immunotechnology, 30 June 2026 for Immuno-Oncology and Immune Cell Engineering, and 10 June 2026 for Experimental Cancer Immunotherapy. Application links are provided via Lund University’s Varbi portal. Contact persons listed in the post include Professor Sara Ek , Professor Filipe Pereira , and Professor Kristian Pietras .